复方丹参注射液联合伊马替尼治疗急性淋巴细胞白血病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R733.71

基金项目:


Clinical Study on Compound Danshen Injection Combined with Imatinib for Acute Lymphoblastic Leukemia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察复方丹参注射液联合伊马替尼对急性淋巴细胞白血病患者造血及免疫功能的影响。方法:选择70 例急性淋巴细胞白血病患者为研究对象,按随机数字表法分为对照组和观察组各35 例。对照组给予化疗+伊马替尼治疗,观察组在对照组基础上给予复方丹参注射液治疗。比较2 组临床疗效,检测治疗前后血白细胞(WBC)、红细胞(RBC)、血小板(BPC) 计数和血红蛋白(Hb) 水平的变化,检测外周血T 淋巴细胞亚群(CD3+,CD4+,CD8+及CD4+/CD8+) 水平的变化。结果:治疗前,2 组外周血WBC、RBC、BPC 计数及Hb 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组外周血RBC、BPC 计数及Hb 水平较治疗前上升,WBC 计数较治疗前下降(P<0.05);且观察组WBC、RBC 及Hb 高于对照组(P<0.05)。治疗前,2 组CD3+、CD4+、CD8+及CD4+/CD8+水平比较,差异无统计学意义(P>0.05)。治疗后,2 组CD3+、CD4+及CD4+/CD8+水平较治疗前降低(P<0.05),但是观察组降低程度小于对照组(P<0.05)。结论:复方丹参注射液联合伊马替尼治疗急性淋巴细胞白血病具有较好的疗效,可以有效改善患者骨髓造血功能和免疫功能。

    Abstract:

    Abstract:Objective:To observe the effect of compound Danshen injection combined with imatinib on hematopoiesis and immune function of patients with acute lymphoblastic leukemia. Methods: A total of 70 cases of patients with acute lymphoblastic leukemia were selected as study objects,and were divided into the control group and the observation group according to the random number table method , with 35 cases in each group. The control group was treated with chemotherapy and imatinib, and the observation group was additionally treated with compound Danshen injection based on the treatment of the control group. The clinical effects in the two groups were compared; the changes in the levels of white blood cell(WBC), red blood cell(RBC), blood platelet count(BPC) and hemoglobin(Hb) before and after treatment were detected;the changes in the levels of T lymphocyte subsets including CD3+,CD4+,CD8+ and CD4 +/CD8 + in peripheral blood were detected. Results: Before treatment, there was no significant difference being found in the comparison of the counts of WBC,RBC,BPC and the Hb levels between the two groups(P>0.05). After treatment,the counts of RBC and BPC and the Hb levels in peripheral blood in the two groups were increased when compared with those before treatment, and WBC counts were decreased(P<0.05); WBC, RBC and Hb in the observation group were higher than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of CD3+,CD4+,CD8+ and CD4+/CD8+ between the two groups(P>0.05). After treatment,the levels of CD3 + , CD4 + and CD4 +/CD8 + in the two groups were decreased when compared with those before treatment(P<0.05),but the decrease in the observation group was less significant than that in the control group(P<0.05). Conclusion: The therapy of compound Danshen injection combined with imatinib has a good curative in the treatment of acute lymphoblastic leukemia, which can effectively improve bone marrow hematopoietic function and immune function of patients.

    参考文献
    相似文献
    引证文献
引用本文

冯沈红,郑仁智,赵建治.复方丹参注射液联合伊马替尼治疗急性淋巴细胞白血病临床研究[J].新中医,2022,54(19):182-185

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-10-08
  • 出版日期:
文章二维码